NR3C1 and rheumatoid arthritis: In addition, four functionally well-characterized polymorphisms of the glucocorticoid receptor (GR) gene (9β, ER22/23EK, BclI and N363S) that modulate GC sensitivity could also partly explain variation in clinical response to GC in patients with RA, as has been shown in other inflammatory diseases [8–12].